Top Industry Leaders in the Huntington’s Disease Treatment Market
Latest Huntington’s Disease Treatment Companies Updates:
Roche partners with NeuExcell Therapeutics for gene therapy research: This collaboration combines expertise to develop potential gene therapy solutions for HD patients.
Spark Therapeutics and F. Hoffmann-La Roche collaborate on genetic therapy: This partnership aims to advance development of gene therapy candidate SPARC131 for HD treatment.
Huntington's Disease Society of America (HDSA): Provides information and resources for patients, families, and healthcare professionals affected by HD.
Genetic Alliance: Advocacy organization representing patients and families affected by genetic conditions, including HD.
List of Huntington’s Disease Treatment Key companies in the market:
- AmpliPhi Biosciences Corp
- Ceregene Inc
- Lundbeck
- Prana Biotechnology Limited
- Teva Pharmaceutical Industries Ltd
- Cortex Pharmaceuticals Inc
- Vertex Pharmaceuticals Incorporated
- Auspex Pharmaceuticals
- SOM Biotech
- GlaxoSmithKline
- Siena Biotech